Use of Charged Aerosol Detection as an Orthogonal Quantification Technique for Drug Metabolites in Safety Testing (MIST)

Importance of the Topic

Early quantification of drug metabolites is crucial to ensure animal models mimic human metabolic profiles as required by US FDA MIST guidelines. Accurate and consistent measurement across diverse compound structures supports safety testing, regulatory compliance, and efficient process development.

Objectives and Study Overview

This work evaluates charged aerosol detection (CAD) as an orthogonal technique to UV and MS for quantifying drug metabolites under in vitro human liver microsome (HLM) incubations. Two test cases are presented: buspirone (strong UV chromophore) and erythromycin (weak UV chromophore).

Methodology and Instrumentation

• Sample preparation: Buspirone and erythromycin were incubated at 1-100 μM with HLM and quenched with acetonitrile.
• Chromatography: SB C18 column (1.8 μm, 4.6×150 mm); mobile phases A (0.1% formic acid in water) and B (0.1% formic acid in acetonitrile); flow rate 1 mL/min; run time 15 min.
• Detection: Parallel UV at 210/220 nm and 254 nm, CAD and high-resolution MS (LTQ Orbitrap) with optimized flow splitting (100-200 μL/min to MS, ≥500 μL/min to CAD).

Main Results and Discussion

• Buspirone metabolites: CAD response displayed 17-20% RSD, outperforming UV at 254 nm (53% RSD) and MS (37% RSD). Six-point CAD calibration from ~4 to 124 ng on column was linear (R2=0.9994). CAD LOD was ~1 ng.
• Erythromycin metabolites: UV detection before incubation failed to detect the parent; post-incubation CAD identified four major metabolites consistent with MS data, enabling quantitation where UV lacked sensitivity.
• System optimization: Precise positioning of the flow splitter and appropriate tubing ID were critical to maintain CAD and MS performance. CAD requires a minimum flow rate of 500 μL/min.
• Complementary strategy: CAD can normalize MS metabolite ratios at higher levels and extend quantitation into low-concentration regimes.

Benefits and Practical Applications

• Structure-independent response allows consistent quantitation of nonvolatile and semivolatile drug metabolites without chromophores.
• Improves confidence in early drug development by providing an orthogonal check against UV and MS methods.
• Reduces reliance on scarce reference standards and costly radiolabelled assays.

Future Trends and Applications

• Integration of CAD with advanced high-resolution MS and micro-flow LC systems.
• Automation and miniaturization to improve sensitivity for in vivo metabolite profiling.
• Implementation of data processing workflows and AI-driven models for rapid metabolite identification and quantitation.

Conclusion

A combined UHPLC-UV-CAD-MS platform offers a robust, complementary quantitation toolkit for drug metabolite analysis in MIST studies. CAD’s uniform response and low-ng sensitivity fill gaps where UV and MS alone may fail, enhancing analytical confidence without significant cost or time penalties.

Reference

1. Guideline on Metabolites in Safety Testing (MIST), US FDA, 2008
2. Cai H. et al. Charged Aerosol Detection with HPLC, UV, and LTQ-Orbitrap MS for Semi-Quantification of Drug Metabolites, ASMS, 2010
3. Zhu H. et al. Drug Metabolism and Disposition, 2005, 33, 500-507